A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study

1. Piñana, J.L.
2. Hernández-Boluda, J.C.
3. Calabuig, M.
4. Ballester, I.
5. Marín, M.
6. Madrid, S.
7. Teruel, A.
8. Terol, M.-J.
9. Navarro, D.
10. Solano, C.